Abnormal amygdala-prefrontal effective connectivity to happy faces differentiates bipolar from major depression
- PMID: 19450794
- PMCID: PMC2740996
- DOI: 10.1016/j.biopsych.2009.03.024
Abnormal amygdala-prefrontal effective connectivity to happy faces differentiates bipolar from major depression
Abstract
Background: Bipolar disorder is frequently misdiagnosed as major depressive disorder, delaying appropriate treatment and worsening outcome for many bipolar individuals. Emotion dysregulation is a core feature of bipolar disorder. Measures of dysfunction in neural systems supporting emotion regulation might therefore help discriminate bipolar from major depressive disorder.
Methods: Thirty-one depressed individuals-15 bipolar depressed (BD) and 16 major depressed (MDD), DSM-IV diagnostic criteria, ages 18-55 years, matched for age, age of illness onset, illness duration, and depression severity-and 16 age- and gender-matched healthy control subjects performed two event-related paradigms: labeling the emotional intensity of happy and sad faces, respectively. We employed dynamic causal modeling to examine significant among-group alterations in effective connectivity (EC) between right- and left-sided neural regions supporting emotion regulation: amygdala and orbitomedial prefrontal cortex (OMPFC).
Results: During classification of happy faces, we found profound and asymmetrical differences in EC between the OMPFC and amygdala. Left-sided differences involved top-down connections and discriminated between depressed and control subjects. Furthermore, greater medication load was associated with an amelioration of this abnormal top-down EC. Conversely, on the right side the abnormality was in bottom-up EC that was specific to bipolar disorder. These effects replicated when we considered only female subjects.
Conclusions: Abnormal, left-sided, top-down OMPFC-amygdala and right-sided, bottom-up, amygdala-OMPFC EC during happy labeling distinguish BD and MDD, suggesting different pathophysiological mechanisms associated with the two types of depression.
Conflict of interest statement
DrPhillips reports having support from NARSAD Independent Investigator Award and 5R01 MH076971-01. DrAlmeida reports having support from CAPES foundation (#190105-2). DrHassel reports having support from NARSAD. DrMechelli, DrVersace, DrQuevedo and DrKupfer reported no biomedical financial interests or potential conflicts of interest.
Figures
References
-
- Murray CJL, Lopez AD. Evidence-based health policy - Lessons from the global burden of disease study. Science. 1996;274:740. - PubMed
-
- Baldessarini RJ, Tondo L. Suicide risk and treatments for patients with bipolar disorder. JAMA. 2003;290:1517–1519. - PubMed
-
- Hirschfeld RM, Vornik LA. Bipolar disorder--costs and comorbidity. Am J Manag Care. 2005;11:S85–S90. - PubMed
-
- Bowden CL. Strategies to reduce misdiagnosis of bipolar depression. Psychiatr Serv. 2001;52:51. - PubMed
-
- Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64:161–174. - PubMed
